MACERICH CO/THE (MAC) Stock Fundamental Analysis

NYSE:MAC • US5543821012

20.3 USD
+0.53 (+2.68%)
At close: Feb 20, 2026
20.3 USD
0 (0%)
After Hours: 2/20/2026, 8:04:00 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

2

MAC gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 123 industry peers in the Diversified REITs industry. MAC may be in some trouble as it scores bad on both profitability and health. MAC has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

  • MAC had negative earnings in the past year.
  • In the past year MAC had a positive cash flow from operations.
  • MAC had negative earnings in 4 of the past 5 years.
  • Of the past 5 years MAC 4 years had a positive operating cash flow.
MAC Yearly Net Income VS EBIT VS OCF VS FCFMAC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

  • With a Return On Assets value of -4.63%, MAC is not doing good in the industry: 80.49% of the companies in the same industry are doing better.
  • The Return On Equity of MAC (-15.55%) is worse than 78.05% of its industry peers.
  • The Return On Invested Capital of MAC (1.79%) is worse than 69.11% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for MAC is in line with the industry average of 3.06%.
  • The last Return On Invested Capital (1.79%) for MAC is above the 3 year average (1.71%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -4.63%
ROE -15.55%
ROIC 1.79%
ROA(3y)-2.25%
ROA(5y)-1.82%
ROE(3y)-6.88%
ROE(5y)-6.09%
ROIC(3y)1.71%
ROIC(5y)1.43%
MAC Yearly ROA, ROE, ROICMAC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10

1.3 Margins

  • MAC's Operating Margin of 17.50% is in line compared to the rest of the industry. MAC outperforms 40.65% of its industry peers.
  • In the last couple of years the Operating Margin of MAC has declined.
  • MAC's Gross Margin of 54.86% is on the low side compared to the rest of the industry. MAC is outperformed by 70.73% of its industry peers.
  • In the last couple of years the Gross Margin of MAC has declined.
Industry RankSector Rank
OM 17.5%
PM (TTM) N/A
GM 54.86%
OM growth 3Y6.69%
OM growth 5Y-4.17%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.18%
GM growth 5Y-2.5%
MAC Yearly Profit, Operating, Gross MarginsMAC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

1

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MAC is destroying value.
  • MAC has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MAC Yearly Shares OutstandingMAC Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
MAC Yearly Total Debt VS Total AssetsMAC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

  • Based on the Altman-Z score of 0.08, we must say that MAC is in the distress zone and has some risk of bankruptcy.
  • MAC has a Altman-Z score of 0.08. This is in the lower half of the industry: MAC underperforms 73.98% of its industry peers.
  • A Debt/Equity ratio of 2.02 is on the high side and indicates that MAC has dependencies on debt financing.
  • MAC has a Debt to Equity ratio of 2.02. This is in the lower half of the industry: MAC underperforms 69.11% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.02
Debt/FCF N/A
Altman-Z 0.08
ROIC/WACC0.29
WACC6.24%
MAC Yearly LT Debt VS Equity VS FCFMAC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.3 Liquidity

  • A Current Ratio of 0.85 indicates that MAC may have some problems paying its short term obligations.
  • Looking at the Current ratio, with a value of 0.85, MAC is in line with its industry, outperforming 46.34% of the companies in the same industry.
  • MAC has a Quick Ratio of 0.85. This is a bad value and indicates that MAC is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.85, MAC is in line with its industry, outperforming 47.97% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.85
Quick Ratio 0.85
MAC Yearly Current Assets VS Current LiabilitesMAC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 73.17% over the past year.
EPS 1Y (TTM)73.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%153.93%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-4.38%

3.2 Future

  • The Earnings Per Share is expected to grow by 23.89% on average over the next years. This is a very strong growth
  • MAC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.05% yearly.
EPS Next Y21.38%
EPS Next 2Y31.32%
EPS Next 3Y40.62%
EPS Next 5Y23.89%
Revenue Next Year-1%
Revenue Next 2Y-0.01%
Revenue Next 3Y1.59%
Revenue Next 5Y2.05%

3.3 Evolution

MAC Yearly Revenue VS EstimatesMAC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 200M 400M 600M 800M 1B
MAC Yearly EPS VS EstimatesMAC Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 1 -1 2 3

More info and screens

Find the best growth stocksShow best growing peers

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for MAC. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MAC. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MAC Price Earnings VS Forward Price EarningsMAC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100

4.2 Price Multiples

  • 73.98% of the companies in the same industry are cheaper than MAC, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 18.1
MAC Per share dataMAC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

  • MAC's earnings are expected to grow with 40.62% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.32%
EPS Next 3Y40.62%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 3.44%, MAC has a reasonable but not impressive dividend return.
  • MAC's Dividend Yield is slightly below the industry average, which is at 6.79.
  • MAC's Dividend Yield is rather good when compared to the S&P500 average which is at 1.81.
Industry RankSector Rank
Dividend Yield 3.44%

5.2 History

  • The dividend of MAC decreases each year by -25.88%.
  • MAC has been paying a dividend for at least 10 years, so it has a reliable track record.
  • MAC has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)-25.88%
Div Incr Years0
Div Non Decr Years3
MAC Yearly Dividends per shareMAC Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

5.3 Sustainability

  • MAC has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-43.75%
EPS Next 2Y31.32%
EPS Next 3Y40.62%
MAC Yearly Income VS Free CF VS DividendMAC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

More info and screens

Find the best dividend stocksShow peers with best dividend

MACERICH CO/THE

NYSE:MAC (2/20/2026, 8:04:00 PM)

After market: 20.3 0 (0%)

20.3

+0.53 (+2.68%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-18
Earnings (Next)05-11
Inst Owners103.36%
Inst Owner Change1.06%
Ins Owners0.31%
Ins Owner Change-0.02%
Market Cap5.20B
Revenue(TTM)N/A
Net Income(TTM)-390.44M
Analysts70
Price Target20.33 (0.15%)
Short Float %5.8%
Short Ratio7.92
Dividend
Industry RankSector Rank
Dividend Yield 3.44%
Yearly Dividend0.64
Dividend Growth(5Y)-25.88%
DP-43.75%
Div Incr Years0
Div Non Decr Years3
Ex-Date03-16
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-207.67%
Min EPS beat(2)-320.79%
Max EPS beat(2)-94.54%
EPS beat(4)0
Avg EPS beat(4)-629.5%
Min EPS beat(4)-1955.13%
Max EPS beat(4)-94.54%
EPS beat(8)2
Avg EPS beat(8)-194.09%
EPS beat(12)3
Avg EPS beat(12)-347.67%
EPS beat(16)3
Avg EPS beat(16)-307.05%
Revenue beat(2)2
Avg Revenue beat(2)1.68%
Min Revenue beat(2)0.51%
Max Revenue beat(2)2.85%
Revenue beat(4)4
Avg Revenue beat(4)9.55%
Min Revenue beat(4)0.51%
Max Revenue beat(4)22.66%
Revenue beat(8)7
Avg Revenue beat(8)6.43%
Revenue beat(12)10
Avg Revenue beat(12)4.74%
Revenue beat(16)13
Avg Revenue beat(16)4.29%
PT rev (1m)2.2%
PT rev (3m)1.6%
EPS NQ rev (1m)-8.56%
EPS NQ rev (3m)-31.41%
EPS NY rev (1m)-19.33%
EPS NY rev (3m)-45.15%
Revenue NQ rev (1m)-1.73%
Revenue NQ rev (3m)-3.54%
Revenue NY rev (1m)-0.91%
Revenue NY rev (3m)-1.5%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.07
P/FCF N/A
P/OCF 15.94
P/B 2.07
P/tB 2.25
EV/EBITDA 18.1
EPS(TTM)-0.22
EYN/A
EPS(NY)-0.17
Fwd EYN/A
FCF(TTM)-0.47
FCFYN/A
OCF(TTM)1.27
OCFY6.28%
SpS4.01
BVpS9.8
TBVpS9.03
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -4.63%
ROE -15.55%
ROCE 2.27%
ROIC 1.79%
ROICexc 1.86%
ROICexgc 1.94%
OM 17.5%
PM (TTM) N/A
GM 54.86%
FCFM N/A
ROA(3y)-2.25%
ROA(5y)-1.82%
ROE(3y)-6.88%
ROE(5y)-6.09%
ROIC(3y)1.71%
ROIC(5y)1.43%
ROICexc(3y)1.73%
ROICexc(5y)1.46%
ROICexgc(3y)1.79%
ROICexgc(5y)1.51%
ROCE(3y)2.16%
ROCE(5y)1.81%
ROICexgc growth 3Y9.63%
ROICexgc growth 5Y-3.26%
ROICexc growth 3Y9.11%
ROICexc growth 5Y-3.53%
OM growth 3Y6.69%
OM growth 5Y-4.17%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.18%
GM growth 5Y-2.5%
F-Score4
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 2.02
Debt/FCF N/A
Debt/EBITDA 9.33
Cap/Depr 122.66%
Cap/Sales 43.58%
Interest Coverage 0.87
Cash Conversion 59.96%
Profit Quality N/A
Current Ratio 0.85
Quick Ratio 0.85
Altman-Z 0.08
F-Score4
WACC6.24%
ROIC/WACC0.29
Cap/Depr(3y)47.12%
Cap/Depr(5y)31.57%
Cap/Sales(3y)15.89%
Cap/Sales(5y)10.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)73.17%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%153.93%
EPS Next Y21.38%
EPS Next 2Y31.32%
EPS Next 3Y40.62%
EPS Next 5Y23.89%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-4.38%
Revenue Next Year-1%
Revenue Next 2Y-0.01%
Revenue Next 3Y1.59%
Revenue Next 5Y2.05%
EBIT growth 1Y-8%
EBIT growth 3Y9.58%
EBIT growth 5Y-4.36%
EBIT Next Year222.29%
EBIT Next 3Y48.88%
EBIT Next 5Y20.9%
FCF growth 1Y-165.99%
FCF growth 3Y-40.36%
FCF growth 5Y-30.47%
OCF growth 1Y9.27%
OCF growth 3Y-0.35%
OCF growth 5Y-4.41%

MACERICH CO/THE / MAC FAQ

What is the fundamental rating for MAC stock?

ChartMill assigns a fundamental rating of 2 / 10 to MAC.


Can you provide the valuation status for MACERICH CO/THE?

ChartMill assigns a valuation rating of 1 / 10 to MACERICH CO/THE (MAC). This can be considered as Overvalued.


How profitable is MACERICH CO/THE (MAC) stock?

MACERICH CO/THE (MAC) has a profitability rating of 2 / 10.


What is the financial health of MACERICH CO/THE (MAC) stock?

The financial health rating of MACERICH CO/THE (MAC) is 1 / 10.